Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

IOBT

IO Biotech (IOBT)

IO Biotech Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IOBT

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
05/14/2024	8:30AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
05/14/2024	8:13AM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
05/14/2024	7:55AM	GlobeNewswire Inc.	IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights	NASDAQ:IOBT	IO Biotech Inc
04/24/2024	4:30PM	GlobeNewswire Inc.	IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
04/15/2024	8:30AM	GlobeNewswire Inc.	IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness	NASDAQ:IOBT	IO Biotech Inc
04/09/2024	12:00PM	GlobeNewswire Inc.	IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103	NASDAQ:IOBT	IO Biotech Inc
04/05/2024	8:30AM	GlobeNewswire Inc.	IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer	NASDAQ:IOBT	IO Biotech Inc
03/11/2024	4:56PM	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IOBT	IO Biotech Inc
03/06/2024	4:11PM	GlobeNewswire Inc.	IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
03/05/2024	5:17PM	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IOBT	IO Biotech Inc
03/05/2024	4:46PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
03/05/2024	4:40PM	GlobeNewswire Inc.	IO Biotech Announces 2023 Fourth-Quarter and Year-End Results	NASDAQ:IOBT	IO Biotech Inc
02/26/2024	4:05PM	GlobeNewswire Inc.	IO Biotech to Present at 44th Annual Cowen Health Care Conference	NASDAQ:IOBT	IO Biotech Inc
01/08/2024	8:11AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
12/21/2023	8:30AM	GlobeNewswire Inc.	IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial	NASDAQ:IOBT	IO Biotech Inc
11/24/2023	5:37PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOBT	IO Biotech Inc
11/13/2023	4:15PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
11/13/2023	8:12AM	GlobeNewswire Inc.	IO Biotech Announces 2023 Third Quarter Results	NASDAQ:IOBT	IO Biotech Inc
11/13/2023	8:10AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
11/13/2023	8:00AM	GlobeNewswire Inc.	IO Biotech Appoints Helen Collins, MD, to its Board of Directors	NASDAQ:IOBT	IO Biotech Inc
11/10/2023	8:00AM	GlobeNewswire Inc.	IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma	NASDAQ:IOBT	IO Biotech Inc
11/08/2023	4:30PM	GlobeNewswire Inc.	IO Biotech Announces Participation in Upcoming Investor Conferences	NASDAQ:IOBT	IO Biotech Inc
11/01/2023	8:30AM	GlobeNewswire Inc.	IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
10/23/2023	1:00AM	GlobeNewswire Inc.	Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Socie	NASDAQ:IOBT	IO Biotech Inc
10/03/2023	4:30PM	GlobeNewswire Inc.	IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
09/12/2023	4:06PM	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NASDAQ:IOBT	IO Biotech Inc
09/12/2023	8:05AM	GlobeNewswire Inc.	IO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancer	NASDAQ:IOBT	IO Biotech Inc
09/11/2023	12:15AM	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IOBT	IO Biotech Inc
09/07/2023	10:36AM	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:IOBT	IO Biotech Inc
09/06/2023	8:35AM	GlobeNewswire Inc.	IO Biotech Announces Participation in Upcoming Investor Conferences	NASDAQ:IOBT	IO Biotech Inc